Surgical resection remains the standard treatment for renal cell carcinoma.
Although historically the concept of wide excision of the affected kidney dictated surgical thinking for more than half a century, a better understanding of the biology of this tumor, standardized staging, and changing patterns of presentation permit today a refined management approach with nephron-sparing surgery, thus limiting potential long-term morbidity by maximizing the preservation of functional renal parenchyma. This paper aims to review the current status of nephron-sparing surgery for solid renal masses with an emphasis on indications, preoperative assessment, and operative technical issues, summarizing the most recent existing data on the subject.
Written by:
González J, Cózar JM, Gómez A, Fernández-Pérez C, Esteban M. Are you the author?
Servicio de Urología, Hospital Central de la Cruz Roja San José y Santa Adela Madrid, Avda. de Reina Victoria 22-26, 28003, Madrid, Spain.
Reference: Curr Urol Rep. 2015 Feb;16(2):6.
doi: 10.1007/s11934-014-0475-5
PubMed Abstract
PMID: 25633842